Clinical Education InitiativeMenu
Search
Home > Courses > New DAAs and New DDIs: How Drug-Drug Interactions Continue To Vex HCV Treatment

New DAAs and New DDIs: How Drug-Drug Interactions Continue To Vex HCV Treatment

New DAAs and New DDIs: How Drug-Drug Interactions Continue To Vex HCV Treatment
New DAAs and New DDIs: How Drug-Drug Interactions Continue To Vex HCV Treatment
Play
Sorry, this learning module is not available for mobile devices.
Resource ID: CM440
Original Presentation: 12/13/2016
Web Posting: 3/20/2017
CE Expiration: 12/12/2019
Presenter
  • Charles W. Flexner, MD
    Professor of Medicine
    John Hopkins University School of Medicine
Learning Objectives
At the completion of this educational session, participants will:
  1. Understand the potential for clinically significant drug-drug interactions involving the most recently approved HCV direct acting agents.
  2. Appreciate differences in the drug interaction potential of ledipasivir and velpatasvir.
  3. Know readily available resources for managing and avoiding HCV DAA drug interactions.
Presenter Bio
Charles Flexner, MD
Charles Flexner is an expert on the basic and clinical pharmacology of drugs for HIV/AIDS and related infections, including viral hepatitis and tuberculosis. His current research includes the discovery and development of new molecules and formulations for long-acting parenteral administration for treatment and prevention of HIV infection. Dr. Flexner is the Deputy Director of the Institute for Clinical and Translational Research at Johns Hopkins, and Co-Principal Investigator of the Johns Hopkins University Baltimore-Washington-India Clinical Trials Unit. He currently serves as a consultant to the Bill and Melinda Gates Foundation and the Clinton Health Access Initiative, and served as a consultant on FDA reform to the United States House of Representatives.
Continuing Education Credit

This CME activity was approved for AMA PRA Category 1 Credit™ on December 13, 2016 and will terminate December 12, 2019.

The target audience is all physicians, NPs and PAs involved or interested in HIV education.

This online video and post-activity evaluation are one hour in length.

  • After you complete the video portion of this educational activity there will be a post-activity evaluation and quiz.
  • You must achieve at least 70% correct to receive your CME certificate.
  • If successful, you will be provided instructions to print your CME certificate at the completion of this activity.

Accreditation Statement

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the Medical Society of the State of New York (MSSNY) and the Physicians’ Research Network (PRN). MSSNY is accredited by the ACCME to provide continuing medical education for physicians.

The Medical Society of the State of New York designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit. Physicians should claim only the credit commensurate with extent of their participation in the activity.

Disclosure Statement 

Policies and standards of MSSNY require that speakers and planners for CME activities disclose any relevant financial relationships they may have with commercial interests whose products, devices or services may be discussed in the content of a CME activity. 

  • Dr. James Braun (Planner/Course Director) had no relevant financial relationships to disclose.
  • Dr. Charles Flexner (Presenter) had no relevant financial relationships to disclose.  Dr. Flexner submitted his slides in advance for adequate peer reiew, and will support his presentation and clinical recommendations with the best available evidence from the medical literature.

Financial Support

This meeting of the Physicians' Research Network (PRN) and enduring material were funded in part by educational grants from: Bristol-Myers Squibb, Gilead Sciences, Janssen Pharmaceuticals, Merck & Co, and ViiV Healthcare.

Details:

  • This online video and post-activity evaluation are one hour in length. 
  • After you complete the video portion of this educational activity there will be a post-activity evaluation and quiz. 
  • You must achieve at least 70% correct to receive your CME certificate. 
  • If successful, you will be provided instructions to print your CME certificate at the completion of this activity.
PRN Learning Modules